| Metabolic gene polymorphism frequencies in control populations S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ... Cancer Epidemiology, Biomarkers and Prevention 10 (12), 1239-1248, 2001 | 1132 | 2001 |
| Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms DW Hein, MA Doll, AJ Fretland, MA Leff, SJ Webb, GH Xiao, ... Cancer Epidemiology, Biomarkers and Prevention 9 (1), 29-42, 2000 | 933 | 2000 |
| N-acetylation pharmacogenetics WW Weber, DW Hein Pharmacol Rev 37, 25-79, 1985 | 844 | 1985 |
| NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses M García-Closas, N Malats, D Silverman, M Dosemeci, M Kogevinas, ... The Lancet 366 (9486), 649-659, 2005 | 763 | 2005 |
| Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis DW Hein Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 506, 65-77, 2002 | 643 | 2002 |
| Nomenclature for N-acetyltransferases KP Vatsis, WW Weber, DA Bell, JM Dupret, DAP Evans, DM Grant, ... Pharmacogenetics and Genomics 5 (1), 1-17, 1995 | 510 | 1995 |
| Acetylator genotype and arylamine-induced carcinogenesis DW Hein Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 948 (1), 37-66, 1988 | 465 | 1988 |
| Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases DW Hein, MA Doll, TD Rustan, K Gray, Y Feng, RJ Ferguson, DM Grant Carcinogenesis 14 (8), 1633-1638, 1993 | 428 | 1993 |
| Clinical pharmacokinetics of isoniazid WW Weber, DW Hein Clinical pharmacokinetics 4, 401-422, 1979 | 279 | 1979 |
| Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice SE McKim, E Gäbele, F Isayama, JC Lambert, LM Tucker, MD Wheeler, ... Gastroenterology 125 (6), 1834-1844, 2003 | 269 | 2003 |
| N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk DW Hein Oncogene 25 (11), 1649-1658, 2006 | 219 | 2006 |
| Etiologic heterogeneity among non-Hodgkin lymphoma subtypes LM Morton, SS Wang, W Cozen, MS Linet, N Chatterjee, S Davis, ... Blood 112 (13), 5150-5160, 2008 | 202 | 2008 |
| A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions TP Reilly, LH Lash, MA Doll, DW Hein, PM Woster, CK Svensson Journal of Investigative Dermatology 114 (6), 1164-1173, 2000 | 189 | 2000 |
| Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms AJ Fretland, MA Leff, MA Doll, DW Hein Pharmacogenetics and Genomics 11 (3), 207-215, 2001 | 181 | 2001 |
| N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women AC Deitz, W Zheng, MA Leff, M Gross, WQ Wen, MA Doll, GH Xiao, ... Cancer Epidemiology, Biomarkers and Prevention 9 (9), 905-910, 2000 | 178 | 2000 |
| Inactivation of GSK-3β by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage and remodeling Y Wang, W Feng, W Xue, Y Tan, DW Hein, XK Li, L Cai Diabetes 58, 1391-1402, 2009 | 175 | 2009 |
| N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk W Zheng, AC Deitz, DR Campbell, WQ Wen, JR Cerhan, TA Sellers, ... Cancer Epidemiology, Biomarkers and Prevention 8 (3), 233-239, 1999 | 175 | 1999 |
| Metabolic Activation of N-Hydroxyarylamines and N-Hydroxyarylamides by 16 Recombinant Human NAT2 Allozymes: Effects of 7 Specific NAT2 Nucleic Acid … DW Hein, MA Doll, TD Rustan, RJ Ferguson Cancer Research 55 (16), 3531-3536, 1995 | 162 | 1995 |
| Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant human wild-type, mutant, and chimeric NAT2 allozymes DW Hein, RJ Ferguson, MA Doll, TD Rustan, K Gray Human Molecular Genetics 3 (5), 729-734, 1994 | 160 | 1994 |
| Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N- acetyltransferases 1 and 2 M Gago-Dominguez, DA Bell, MA Watson, JM Yuan, JE Castelao, ... Carcinogenesis 24 (3), 483-489, 2003 | 157 | 2003 |
J Christopher StatesUniversity of LouisvilleVerified email at louisville.edu
